Special Offers
100% Performance Guaranteed
Key Specifications Table
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H, M | IH(P), ICC, IP, WB, IF, ABA | M | Purified | Monoclonal Antibody |
| Description | |
|---|---|
| Catalogue Number | MAB343-C |
| Description | Anti-APP Antibody, CT, clone 2.F2.19B4, Ascites Free |
| Alternate Names |
|
| Background Information | Amyloid beta A4 protein (UniProt P05067; also known as ABPP, Alzheimer disease amyloid protein, Amyloid precursor protein, APP, APPI, Cerebral vascular amyloid peptide, CVAP, PN-II, PreA4, Protease nexin-II) is encoded by the APP (also known as A4, AD1) gene (Gene ID 351) in human. Amyloid precursor protein (APP) is initially produced with a signal peptide sequence (a.a. 1-17), the removal of which yields the mature protein with a large extracellular portion (a.a. 18-699), followed by a transmembrane segment (a.a. 700-723) and a cytoplasmic (a.a. 724-770) tail. APP can be further processed by the α-, β-, and γ-secretases in two alternative processing pathways. In the non-amyloidogenic pathway, APP is first cleaved by the plasma membrane-localized α-secretase to generate an N-terminal extracellular sAPPα fragment (a.a. 18-687) and a membrane-bound C-terminal fragment C83 (CTFα), which can be further cleaved by γ-secretase to produce a non-toxic small peptide p3 and a cytoplasmic APP intracellular domain (AICD). In the amyloidogenic pathway, APP undergoes β-cleavage in BACE-1 (β-site APP-cleaving enzyme)-enriched endosomes to generate an N-terminal extracellular sAPPβ fragment (a.a. 18-671) and a membrane-bound C-terminal fragment C99 (CTFβ). Subsequent cleavage of C99 by γ-secretase releases the amyloid β peptides, Aβ1-42 (672-713) & Aβ1-40 (672-711), and AICD. Aβ accumulation in the cortical and hippocampal regions of the brain is a major pathological feature of Alzheimers disease (AD). Aβ Ser8 phosphorylation is shown to promote Aβ aggregation into oligomeric and fibrillar assemblies and to prevent Aβ proteolytic clearance by certain proteases. |
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mm NaCl with 0.05% sodium azide. |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application | This Anti-APP Antibody, CT, clone 2.F2.19B4, Ascites Free is validated for use in Immunohistochemistry (Paraffin), Immunocytochemistry, Immunoprecipitation, Western Blotting, Immunofluorescence, Affinity Binding Assay for the detection of APP. |
| Key Applications |
|
| Application Notes | Immunocytochemistry Analysis: A representative lot detected a greatly enhanced nuclear APP immunoreactivity due to an upregulated AICD generation and nuclear localization in HSV-1-infected SH-SY5Y cells by fluorescent immunocytochemistry (De Chiara, g., et Al. (2010). PLoS One. 5(11):e13989). Immunocytochemistry Analysis: A representative lot immunostained neural progenitor cells (NPCs) isolated from the lateral ventricles of E14 mouse brain by fluorescent immunocytochemistry (Ma, Q.H., et Al. (2008). Nat. Cell Biol. 10(3):283-294). Immunoprecipitation Analysis: A representative lot immunoprecipitated APP and cleaved APP C-terminal fragments from uninfected and HSV-1-infected SH-SY5Y cells (De Chiara, g., et Al. (2010). PLoS One. 5(11):e13989). Western Blotting Analysis: A representative lot detected APP and cleaved APP C-terminal fragments in lysates and APP immunoprecipitates from uninfected and HSV-1-infected SH-SY5Y cells (De Chiara, g., et Al. (2010). PLoS One. 5(11):e13989). Western Blotting Analysis: Representative lots detected the stably expressed full-length human APP695 in HEK293-derived BA-3 cells (Hwang, E.M., et Al. (2008). Bioorg. Med. Chem. 16(14):6669-6674; Yeon, S.W., et Al. (2007). Peptides. 28(4):838-844). Immunofluorescence Analysis: A representative lot immunostained the walls of the lateral ventricles in E14 mouse brain tissue sections by fluorescent immunohistochemistry (Ma, Q.H., et Al. (2008). Nat. Cell Biol. 10(3):283-294). Affinity Binding Assay Analysis: A representative lot captured the synthetic peptide representing APP770 a.a. 732-751 or APP695 a.a. 657-676 (Van Vickle, g.D., et Al. (2007). Biochemistry. 46(36):10317-10327). |
| Biological Information | |
|---|---|
| Immunogen | APP C-terminal 53-a.a. fragment. |
| Epitope | APP770 a.a. 732-751 (APP695 a.a. 657-676). |
| Clone | 2.F2.19B4 |
| Concentration | Please refer to lot specific datasheet. |
| Host | Mouse |
| Specificity | Clone 2.F2.19B4, also known as the Jonas antibody, regcognizes a C-terminal epitope present in 10 of the 11 human spliced isoforms reported by UniProt (P05067), with APP305 being the only spliced isoform lacking the targeted epitope. Clone 2.F2.19B4 recognizes full-length APP, the APP C-terminal fragments (CTFs) produced by α- and β-secretase cleavage, and the APP intracellular domain (AICD) generated by γ-secretase cleavage, but not the sAPPα or sAPPβ fragment. Epitope has been mapped to APP770 a.a. 732-751, which is equivalent to APP695 a.a. 657-676 (Van Vickle, g.D., et Al. (2007). Biochemistry. 46(36):10317-10327). |
| Isotype | IgG1κ |
| Species Reactivity |
|
| Species Reactivity Note | Human, Mouse. |
| Antibody Type | Monoclonal Antibody |
| Entrez Gene Number |
|
| Gene Symbol |
|
| Purification Method | Protein g purified. |
| UniProt Number |
|
| Molecular Weight | 85.18/86.94 kDa (APP770), 75.00/76.76 kDa (L-APP677), 76.90/78.66 kDa (APP695), 77.10/78.87 kDa (L-APP696), 79.01/80.77 kDa (APP714), 81.15/82.92 kDa (L-APP733), 83.06/84.82 kDa (APP751), 83.28/85.04 kDa (L-APP752), 70.79/72.55 kDa (APP639), and 82.76/84.52 kDa (isoform 11) calcualted (full-length mature/pro-form). |
| Product Usage Statements | |
|---|---|
| Quality Assurance | Evaluated by Immunohistochemistry in normal and AD human brain tissue sections. Immunohistochemistry Analysis: A 1:50 dilution from a representative lot detected APP immunoreactivity in normal human cerebral cortex and Alzheimers diseased (AD) brain tissue sections. |
| Usage Statement |
|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 μg |